Ozonation of ibuprofen: A degradation and toxicity study

Science of the Total Environment

Volumn 466-467, Issue , 2014, Pages 957-964

  Quero Pastor, M J ^a   Garrido Perez, M C ^a   Acevedo, A ^a   Quiroga, J M ^a  

^a UNIVERSITY OF CÁDIZ   (Spain)

Author keywords

Ibuprofen; Ozone; Pilot plant; Selenastrum capricornium; Toxicity

Indexed keywords

DEGRADATION EFFICIENCY; HYDRAULIC RETENTION TIME; IBUPROFEN; INITIAL CONCENTRATION; INTERMEDIATE COMPOUND; OPTIMAL OPERATING CONDITIONS; PILOT-SCALE REACTORS; SELENASTRUM CAPRICORNIUM;

DEGRADATION; LIQUID CHROMATOGRAPHY; OPTIMIZATION; OZONIZATION; PILOT PLANTS; TOXICITY;

OZONE;

IBUPROFEN; OZONE; WATER POLLUTANT;

ALGA; ANTIBIOTIC RESISTANCE; CONCENTRATION (COMPOSITION); CONDUCTIVITY; DEGRADATION; LIQUID CHROMATOGRAPHY; OZONE; PH; TOXICITY;

AQUEOUS SOLUTION; ARTICLE; CONDUCTANCE; DEGRADATION; DRUG OXIDATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDRAULIC CONDUCTIVITY; LIQUID LIQUID EXTRACTION; MINERALIZATION; OZONATION; PH; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; CHEMISTRY; DRUG EFFECTS; EVALUATION STUDY; GREEN ALGA; OXIDATION REDUCTION REACTION; PROCEDURES; SEWAGE; TOXICITY; WATER POLLUTANT; WATER QUALITY;

CHLOROPHYTA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HYDROGEN-ION CONCENTRATION; IBUPROFEN; OXIDATION-REDUCTION; OZONE; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL; WATER QUALITY;

EID: 84883040599     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2013.07.067     Document Type: Article

References (52)

1. Al-Ahmad A., Daschner F.D., Kümmerer K. Biodegradability of cefotiam ciprofloxacin, meropenem, penicillin G, and sulfamethoxazole and inhibition of waste water bacteria. Environ Contam Toxicol 1999, 37(2):158-163.
2. Alder M.G., Hill G.R. The kinetics and mechanism of hydroxide ion catalyzed ozone decomposition in aqueous solution. J Am Chem Soc 1950, 72(5):1884-1886.
3. Andreozzi R., Caprio V., Ciniglia C., Champdoré M., Giudice R., Marotta R., et al. Antibiotics in the environment: occurrence in Italian STPs, fate, and preliminary assessment on algal toxicity of amoxicillin. Environ Sci Technol 2004, 38(24):6832-6833.
4. Ashbolt N.J. Risk analysis of drinking water microbial contamination versus disinfection by-products (DBPs). Toxicology 2004, 198(1-3):255-262.
5. Bahr C. Suva as control parameter for the effective ozonation of organic pollutants in secondary effluent. Water Sci Technol 2007, 55(12):267-274.
6. Buser H.R., Poiger T., Muller M.D. Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ Sci Technol 1999, 33(15):2529-2535.
7. Camel V., Bermond A. The use of ozone and associated oxidation processes in drinking water treatment. Water Res 1998, 32(11):3208-3222.
8. Carballa M., Omil F., Lema J.M., Llompart M., García-Jares C., Rodríguez I., et al. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 2004, 38(12):2918-2926.
9. Cleavers M. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol Environ Saf 2004, 59(3):309-315.
10. Coelho A., Sans C., Esplugas S., Dezotti M. Ozonation of NSAID: biodegradability and toxicity study. Ozone Sci Eng 2010, 32:91-98.
11. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Perspect 1999, 107(6):907-938.
12. Fent K., Westona A.A., Caminadaa D. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 2006, 76(2):122-159.
13. Fernandez-Carballido A., Herrero-Vanrell R., Molina-Martínez L.T., Pastoriza P. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration: effect of Labrafil addition on release in vitro. Int J Pharm 2004, 279(1-2):33-41.
14. Ferré M., Ferrer I., Ginebrada A., Figueras M., Olivella L., Tirapu L., et al. Determination of drugs in surface water and wastewater samples by liquid chromatography-mass spectrometry: methods and preliminary results including toxicity studies with Vibrio fischeri. J Chromatogr A 2001, 938(1-2):187-197.
15. Garrido-Perez M.C., Perales-Vargas Machuca J.A., Nebot-Sanz E., Sales-Márquez D. Effect of the test media and toxicity of LAS on the growth of Isochrysis galbana. Ecotoxicology 2008, 17(8):738-746.
16. Garrison A.W., Pope J.D., Allen F.R. GC/MS analysis of organic compounds in domestic wastewaters. Identification and analysis of organic pollutants in water 1976, 517-566. Ann Arbor Science, Ann Arbor, MI, [book]. C.H. Keith (Ed.).
17. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data 2002, 131(1-2):5-17.
18. Heberer T., Stan H.J. Determination of trace levels of dichlorprop, mecoprop, clofibric acid, and naphthylacetic acid in soil by gas chromatography/mass spectrometry with selected-ion monitoring. J AOAC Int 1996, 79(6):1428-1433.
19. Hignite C., Azarnoff D.L. Drugs and drug metabolites as environmental contaminants: chlorophenoxyisobutyrate and salicylic acid in sewage water effluent. Life Sci 1977, 20(2):337-342.
20. Hoigne J. Chemistry of aqueous ozone and transformation of pollutants by ozonation and advanced oxidation processes. Handb Environ Chem 1998, 5:83-142.
21. Hoigne J., Bader H. The role of hydroxyl radical reactions in ozonation processes in aqueous solutions. Water Res 1976, 10(5):376-386.
22. Hoigne J., Bader H., Haag W.R., Staehelii J. Rate constants of reactions of ozone with organic and inorganic compounds in water-III. Inorganic compounds and radicals. Water Res 1985, 19(8):993-1004.
23. Hua W., Bennett E.R., Letcher R.J. Ozone treatment and the depletion of detectable pharmaceuticals and antrazine herbicide in drinking water sourced from the upper Detroit River, Ontario, Canada. Water Res 2006, 40(12):2259-2266.
24. Huber M., Canonica S., Park G.Y., von Gunten U. Oxidation of pharmaceuticals during ozonation and advanced oxidation process. Environ Sci Technol 2003, 37(5):1016-1024.
25. Huber M., Gobel A., Joss A., Hermann N., Loffler D., Mcardell C., et al. Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study. Environ Sci Technol 2005, 39(11):4290-4299.
26. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ Sci Technol 2002, 36(6):1202-1211.
27. Kosak-Channing L.F., Helz G.R. Solubility of ozone in aqueous solutions of 0-0.6M ionic strength at 5-30.degree.C. Environ Sci Technol 1983, 17(3):145-149.
28. Lopez-Galindo C., Garrido-Perez M.C., Casanueva J.F., Nebot E. Degradation models and ecotoxicity in marine waters of two antifouling compounds: sodium hypochlorite and an alkylamine surfactant. Sci Total Environ 2010, 408(8):1779-1785.
29. Mendez Arriaga F., Maldonado M.I., Gimenez J., Esplugas S., Malato S. Abatement of ibuprofen by solar photocatalysis process: enhancement and scale up. Catal Today 2009, 144(1-2):112-116.
30. Meunier L., Canonica S., Von Gunten U. Implications of sequential se of UV and Ozone for drinking water quality. Water Res 2006, 40:1864-1876.
31. Muthukumara M., Sargunamania D., Selvakumara N., Venkata Raob J. Optimisation of ozone treatment for colour and COD removal of acid dye effluent using central composite design experiment. Dyes Pigments 2004, 63(2):127-134.
32. Oh H.J., Kim W.J., Choi J.S., Gee C.S., Hwang T.M., Kang J.G., et al. Optimization and control of ozonation plant using raw water characterization method. Ozone Sci Eng 2003, 25(5):383-392.
33. Persson Stubberud K., Astrom O. Separation of ibuprofen, codeine phosphate, their degradation products and impurities by capillary electrophoresis II. Validation. J Chromatogr A 1998, 826(1):95-102.
34. Petrovic M., Eljarrat E., Lopez de Alda M.J., Barcelo D. Endocrine disrupting compounds and other emerging contaminants in the environment: a survey on new monitoring strategies and occurrence data. Anal Bioanal Chem 2004, 378(3):549-562.
35. Richards S.M., Cole S.E. A toxicity and hazard assessment of fourteen pharmaceuticals to Xenopus laevis larvae. Ecotoxicology 2006, 15(8):647-656.
36. Richardson M.L., Bowron J.M.J. The fate of pharmaceutical chemicals in the aquatic environment. Pharma Pharmacol 1985, 37(1):1-12.
37. Ried A., Mielcke J. Ozone and UV: a tool for 'multi-barrier concepts' in water treatment. Water Sci Technol Water Supply 2006, 6(4):17-25.
38. Rodríguez Vidal F.J. Procesos de potabilización del agua e influencia del tratamiento de ozonización. Ediciones Diaz De Santos SA 2003, 13-33.
39. Rogers I.H., Birtwell I.K., Kruzynski G.M. Organic extractables in municipal wastewater Vancouver, British Columbia. Water Pollut Res J Can 1986, 21(2):187-204.
40. 2 in a biotreated municipal wastewater. Water Res 2008, 42(14):3719-3728.
41. Sotelo J.L., Beltrán F.J., Benitez F.J., Beltrán-Heredia J. Henry's law constant for the ozone water system. Water Res 1989, 23(10):1239-1246.
42. Staehelln J., Hoigné J. Decomposition of ozone in water: rate of initiation by hydroxide ions and hydrogen peroxide. Environ Sci Technol 1982, 16(10):676-681.
43. Sudhakaran S., Lattemann S., Amy G.L. Appropriate drinking water treatment processes for organic micropollutants removal based on experimental and model studies-a multi-criteria analysis study. Sci Total Environ 2013, 442:478-488.
44. Ternes T. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 1998, 32(11):3245-3260.
45. Ternes T.A., Stumpf M., Schuppert B., Haberer K. Simultaneous determination of antiseptics and acidic drugs in sewage and river water. Vom Wasser 1998, 90:295-309.
46. Ternes T.A., Meisenheimer M., McDowell D., Sacher F., Brauch H.-J., Haist-Gulde B., et al. Removal of pharmaceuticals during drinking water treatment. Environ Sci Technol 2002, 36(17):3855-3863.
47. Ternes T.A., Stuber J., Herrmann N., McDowell D., Ried A., Kampmann M., et al. Ozonation: a tool for removal of pharmaceuticals, contrast media, and musk fragrances from wastewater. Water Res 2003, 37(8):1976-1982.
48. Von Gunten U. Ozonation of drinking water: part I. Oxidation kinetics and product formation. Water Res 2003, 37:1443-1467.
49. Westerhoff P., Yoon Y., Snyder S., Wert E. Fate of endocrine disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ Sci Technol 2005, 39(17):6649-6663.
50. Wu Q., Shi H., Adams C.D., Timmons T., Ma Y. Oxidative removal of selected endocrine-disruptors and pharmaceuticals in drinking water treatment systems, and identification of degradation products of triclosan. Sci Total Environ 2012, 439:18-25.
51. Zwiener C., Frimmel F.H. Oxidative treatment of pharmaceuticals in water. Water Res 2000, 34(6):1881-1885.
52. Zwiener C., Seeger S., Glauner T., Frimmel F.H. Metabolites from the biodegradation of pharmaceutical residues of ibuprofen in biofilm reactors and batch experiments. Anal Bioanal Chem 2002, 372(4):569-575.